Thermo Fisher Q3 2026: revenue at $12.14 billion and adjusted EPS above expectations
FROM THE WIRE · FINANCE.YAHOO.COM
TMO Q3 deep dive: pharma demand, AI integration, and end-market recovery drive momentum Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 2026 results beating Wall Street's revenue expectations , with sales up 9.1% year on year to $12.14 billion. Its non-GAAP profit of…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishQuarterly results beat consensus estimates for a large life sciences company, relevant for the sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue of $12.14 billion, up 9.1% year on year and above estimates.
- 02Non-GAAP earnings of $6.68 per share, 4.3% above consensus.
- 03Operating margin at 18.6%, versus 17.5% in the same quarter last year.
- 04Market capitalization stands at $256.6 billion.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets